Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Canadian chemical industry news
15 April 2026
PPG acquires pavement-marking maker Ozark Materials
All-cash $65M purchase of a U.S. pavement-marking supplier serving US and Canada. About 130 employees; strengthens Traffic Solutions and North American market presence.
15 April 2026
GSK acquires 35Pharma for $950m
Deal closed for biotech developing HS235, an activin‑receptor therapy for pulmonary hypertension; designed to cut bleeding risk and offer metabolic benefits. PoC trials in PAH and PH‑HFpEF planned.
14 April 2026
OCI Global sells 2M Methanex shares for ~$116.6M
Block trade on 13 April; ownership fell from ~6.0% to ~3.4%. Transaction was for investment purposes; company may repurchase or further sell shares depending on market and the stock's performance.
10 April 2026
Eni invests US$70M in Nouveau Monde Graphite
US$70M in a US$297M raise to fund Matawinie & Becancour; investor gains ~11.5% stake and board seat, secures exclusive graphite/anode supply for Brindisi gigafactory; pending AGM approval
2 April 2026
ABO Energy Advances International Projects
Sold rights to 63 MW wind project in New Brunswick (with PPA); signed Owner’s Engineering for 64.86 MWp Belorado I solar in Spain; received final payment for sold 200 MW Colombian solar project.
31 March 2026
OMV and XRG form Borouge International
Merger of Borouge, Borealis and NOVA creates global pure‑play polyolefins leader with 13.6 Mtpa capacity, >$500M synergies, advantaged feedstock and investment‑grade ratings
How does the Canadian chemical industry perform?
Find out with
chemXplore Alpha
Learn more
31 March 2026
Johnson Matthey DPFi DPF earns Canadian CSA certification
Electrically regenerating diesel particulate filter certified by CSA for Canadian underground mining/tunnelling; also certified by Canmet and VERT and approved by US MSHA.
28 March 2026
Amgen: Repatha cuts first major cardiovascular events 31% in high‑risk patients without significant atherosclerosis
VESALIUS‑CV subgroup (3,655 high‑risk diabetics without known atherosclerosis) showed a 31% reduction in first major CV events vs placebo; median LDL‑C 44 mg/dL over ~4.8 years.
28 March 2026
Takeda’s Zasocitinib: Once‑daily pill achieves rapid, durable clearance in plaque psoriasis
Phase 3: ~70% reached sPGA 0/1 at week 16; PASI90 up to 61%, PASI100 up to 33%. Responses rose through week 24 and >90% of responders maintained effect to week 60. Safety consistent with prior studies
27 March 2026
Eastman raises ester prices effective April 1, 2026
isobutyl acetate +$0.15/lb (NA, LatAm), +$0.28/lb (APAC); n-butyl (excl Eastapure) +$0.15/lb (NA, LatAm); n-propyl +$0.15/lb (NA, LatAm). Cited higher raw-material and energy costs.
26 March 2026
ADNOC and OMV appoint executive team for Borouge Group International AG
Roger Kearns, Dr. Stefan Doboczky and Dr. Hasan Karam to lead; interim CFO until May 2026; supervisory board set; deal on track to close by end‑March 2026, forming a global polyolefins leader
26 March 2026
OMV and ADNOC appoint Borouge Group International AG executive team
Appointed CEO Roger Kearns, CCO Dr. Stefan Doboczky, COO Dr. Hasan Karam; interim CFO Daniel Turnheim until May 2026. Appointments precede planned combination and acquisition closing by Mar 2026.
19 March 2026
ADNOC and OMV advance formation of Borouge Group International AG
Agreement allows marketing of B4 volumes, adds ~$400M net over 3 years (~10% EPS accretion), supports 16.2 fils dividend, targets strong credit ratings; transactions close ~Mar 2026.
19 March 2026
GSK: Lynavoy (linerixibat) FDA-approved for cholestatic pruritus in PBC
FDA approved linerixibat for cholestatic pruritus in adults with PBC after GLISTEN phase III showed rapid, sustained itch and sleep improvements. Common AEs: diarrhea, abdominal pain.
19 March 2026
Clariant opens pharma-grade PEG manufacturing plant in Texas
GMP-compliant excipient production strengthens supply-chain resilience, shortens lead times, and improves continuity and traceability for pharma customers across North & Latin America.
17 March 2026
Kemira obtains PMRA approval in Canada for KemConnect DEX
Chlorine-free performic-acid wastewater disinfection; used in Paris 2024 wastewater works. Combines on-site generation, real-time monitoring and dosing algorithm. Canada rollout pending approvals
17 March 2026
BASF Agricultural Solutions invests €17M to expand Saskatoon canola breeding centre
Construction 2026–2027 adds automation, genomic-selection pipelines and a research glasshouse to boost breeding throughput, speed genetic gain and deliver higher-yield, disease-resistant hybrids
16 March 2026
OCI Sells Methanex Shares
OCI sold 3.3 million Methanex shares for $172.6 million, reducing its stake from 12.9% to 8.6%. Future transactions depend on market conditions and Methanex's performance.
12 March 2026
LBB Specialties Expands Personal Care Portfolio with Sasol
Expanded personal-care portfolio through a partnership with a global chemicals manufacturer, adding access to a broad range of specialty and commodity ingredients for diverse applications.
12 March 2026
Evonik and IMCD Expand U.S. Distribution for VISIOMER® Methacrylates
IMCD will distribute VISIOMER® Specialty Methacrylates in the U.S., enhancing support for coatings, adhesives, construction, and more.
11 March 2026
Elkem Restructures and Cuts Costs to Boost Competitiveness
Elkem introduces a new structure, reduces workforce by 300, and cuts costs by NOK 1.9 billion to enhance profitability amid market challenges.
9 March 2026
Shell Sells Jiffy Lube and Premium Velocity Auto to Monomoy Capital Partners
Shell sells Jiffy Lube and Premium Velocity Auto for $1.3B, retaining other lubricant brands. A long-term supply agreement is included. Closing expected in H2 2026, pending approvals.
9 March 2026
GSK and Alfasigma License Agreement for Linerixibat Rights
Alfasigma gains global rights to develop and market linerixibat for cholestatic pruritus in PBC. GSK to receive payments and royalties. Regulatory reviews are ongoing.
6 March 2026
TotalEnergies Releases Independent Review of Tilenga Project Land Acquisition in Uganda
The assessment confirms compliance with land acquisition standards. An action plan addresses livelihood restoration, support for vulnerable households, grievance management, and gender considerations.
6 March 2026
Silox Acquires BASF's Hydrosulfite Assets
Silox strengthens its position in paper and textile industries by acquiring BASF's hydrosulfite assets, enhancing service to European customers and expanding global market presence.
3 March 2026
Dow Receives CAD $1.62 Billion from NOVA After Court Decision
Dow received CAD $1.8 billion, including damages and costs, after NOVA's appeal was denied. The payment is subject to tax withholding, expected to be refunded by year-end.
2 March 2026
EIB and Canada Collaborate on Raw Material Resilience
A Letter of Intent was signed to enhance cooperation on critical raw materials, aiming to secure sustainable supply chains for Europe's green and digital transitions.
2 March 2026
thyssenkrupp Uhde to Study Biomass-to-Methanol Integration for Nova Sustainable Fuels in Canada
The study will assess the integration of gasification and methanol synthesis to produce 450,000 metric tons of bio-methanol annually, aiding decarbonization in transportation and shipping.
26 February 2026
GSK's Linerixibat Gets Priority Review in China for PBC-Related Itch
Linerixibat shows significant improvement in cholestatic pruritus in PBC patients, based on GLISTEN phase III trial data. Regulatory reviews ongoing in US, EU, UK, and Canada.
25 February 2026
Vopak Announces Record 2025 Results and EUR 1.7 Billion Shareholder Program
Net profit rose 61% to EUR 604M. Operating cash flow hit EUR 823M. EUR 4B investment by 2030 planned. EUR 1.1B in growth projects underway. Energy transition projects worth EUR 200M in progress.
Next →
